ATE226087T1 - Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon - Google Patents
Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferonInfo
- Publication number
- ATE226087T1 ATE226087T1 AT99936659T AT99936659T ATE226087T1 AT E226087 T1 ATE226087 T1 AT E226087T1 AT 99936659 T AT99936659 T AT 99936659T AT 99936659 T AT99936659 T AT 99936659T AT E226087 T1 ATE226087 T1 AT E226087T1
- Authority
- AT
- Austria
- Prior art keywords
- cell death
- synergism
- interferon
- inducing agents
- novel cell
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 2
- 108010050904 Interferons Proteins 0.000 title abstract 2
- 230000030833 cell death Effects 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 230000034994 death Effects 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 229940047124 interferons Drugs 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Coils Or Transformers For Communication (AREA)
- Inorganic Fibers (AREA)
- Filters And Equalizers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809886A FR2781674B1 (fr) | 1998-07-31 | 1998-07-31 | Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons |
| PCT/FR1999/001901 WO2000007616A2 (fr) | 1998-07-31 | 1999-07-30 | Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226087T1 true ATE226087T1 (de) | 2002-11-15 |
Family
ID=9529292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99936659T ATE226087T1 (de) | 1998-07-31 | 1999-07-30 | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7217413B1 (de) |
| EP (1) | EP1100528B1 (de) |
| JP (3) | JP2002522395A (de) |
| AT (1) | ATE226087T1 (de) |
| AU (1) | AU5168099A (de) |
| DE (1) | DE69903559T2 (de) |
| DK (1) | DK1100528T3 (de) |
| ES (1) | ES2181461T3 (de) |
| FR (1) | FR2781674B1 (de) |
| PT (1) | PT1100528E (de) |
| WO (1) | WO2000007616A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ296799A0 (en) | 1999-09-20 | 1999-10-14 | Unisearch Limited | A cell-membrane impermeable trivalent organoarsenical derivative and use thereof |
| AUPR379801A0 (en) | 2001-03-19 | 2001-04-12 | Unisearch Limited | Use of a substantially cell membrane impermeable compound for treating arthritis |
| AUPR874601A0 (en) * | 2001-11-08 | 2001-11-29 | Unisearch Limited | Selective targeting of apoptotic cells |
| FR2838965B1 (fr) | 2002-04-26 | 2004-06-25 | Centre Nat Rech Scient | Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme |
| US8394422B2 (en) | 2002-04-26 | 2013-03-12 | Centre National De La Recherche Scientifique (Cnrs) | Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans |
| WO2004028474A2 (en) * | 2002-09-25 | 2004-04-08 | University Of Rochester | Caspase inhibitors as anticancer agents |
| EP2088206B1 (de) | 2002-11-07 | 2013-07-03 | Newsouth Innovations Pty Limited | Induktion des Mitochondrienpermeabilitätsübergangs |
| JP2010222289A (ja) * | 2009-03-23 | 2010-10-07 | Tokyoto Igaku Kenkyu Kiko | 細胞死を予防するための医薬剤 |
| US8784797B2 (en) | 2009-12-15 | 2014-07-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma |
| JP7189399B2 (ja) * | 2017-01-18 | 2022-12-14 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 骨髄増殖性障害を患う患者の処置のための方法及び医薬組成物 |
| JP7336359B2 (ja) * | 2019-03-13 | 2023-08-31 | 株式会社明電舎 | 配電系統制御装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| US20020001841A1 (en) * | 1998-06-26 | 2002-01-03 | Keld Kaltoft | Continuous t-cell lines |
| ATE391791T1 (de) * | 2000-08-25 | 2008-04-15 | Aventis Pharma Inc | Membran penetrierende peptide und deren anwendungen |
-
1998
- 1998-07-31 FR FR9809886A patent/FR2781674B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-30 PT PT99936659T patent/PT1100528E/pt unknown
- 1999-07-30 AU AU51680/99A patent/AU5168099A/en not_active Abandoned
- 1999-07-30 ES ES99936659T patent/ES2181461T3/es not_active Expired - Lifetime
- 1999-07-30 WO PCT/FR1999/001901 patent/WO2000007616A2/fr not_active Ceased
- 1999-07-30 DE DE69903559T patent/DE69903559T2/de not_active Expired - Lifetime
- 1999-07-30 US US09/744,605 patent/US7217413B1/en not_active Expired - Fee Related
- 1999-07-30 AT AT99936659T patent/ATE226087T1/de not_active IP Right Cessation
- 1999-07-30 JP JP2000563299A patent/JP2002522395A/ja not_active Withdrawn
- 1999-07-30 EP EP99936659A patent/EP1100528B1/de not_active Expired - Lifetime
- 1999-07-30 DK DK99936659T patent/DK1100528T3/da active
-
2011
- 2011-06-22 JP JP2011138614A patent/JP2011190280A/ja active Pending
-
2014
- 2014-03-05 JP JP2014042962A patent/JP2014129404A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1100528B1 (de) | 2002-10-16 |
| DE69903559D1 (de) | 2002-11-21 |
| EP1100528A2 (de) | 2001-05-23 |
| WO2000007616A2 (fr) | 2000-02-17 |
| WO2000007616A3 (fr) | 2000-04-20 |
| JP2002522395A (ja) | 2002-07-23 |
| US7217413B1 (en) | 2007-05-15 |
| DE69903559T2 (de) | 2003-02-27 |
| AU5168099A (en) | 2000-02-28 |
| JP2014129404A (ja) | 2014-07-10 |
| DK1100528T3 (da) | 2002-11-04 |
| JP2011190280A (ja) | 2011-09-29 |
| PT1100528E (pt) | 2002-12-31 |
| ES2181461T3 (es) | 2003-02-16 |
| FR2781674A1 (fr) | 2000-02-04 |
| FR2781674B1 (fr) | 2002-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8606289A1 (es) | Un procedimiento para la preparacion de piridazinaminas. | |
| DE3869184D1 (de) | Festelektrolyt-brennstoffzelle und zusammenbau. | |
| NO960743L (no) | Cellulære preparater, deres fremstilling og terapeutiske anvendelse | |
| ATE357509T1 (de) | Stimulierung von hämatopoietischen zellen im vitro | |
| IT8519102A0 (it) | Composizione di organopolisilossano polimerizzabile in un elastomero e relativo impiego. | |
| DE68912331D1 (de) | Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität. | |
| CY1108459T1 (el) | Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων | |
| ES2043607T3 (es) | Agentes fibrinoliticos modificados. | |
| ATE226087T1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
| FR2662698B1 (de) | ||
| DK1032672T3 (da) | DNA19355-polypeptid, en tumornekrosefaktor-homolog | |
| TR199902730T2 (xx) | Glikrizikasit ve antiviral etkinlik kazand�r�lm�� en az�ndan bir proteini i�eren farmas�tik antiviral bile�im. | |
| ATE75778T1 (de) | Immunosuppressionsfaktor. | |
| TR199802648A2 (xx) | Gen tedavisi i�in n�klein asit yap�lar�. | |
| DE3381467D1 (de) | Plasmaproteinkonzentrate mit reduzierter thrombogenizitaet und deren verwendung in klinischer ersatztherapie. | |
| NO162775C (no) | Isolator for anvendelse i elektrolyseceller. | |
| IT8347560A0 (it) | Polipeptide dotato di attivita' di interferon, composizione che lo con tiene e procedimento di preparazione | |
| NZ503401A (en) | Use of interferon-beta (IFN-B) genes for the treatment of cancer | |
| DE3585049D1 (de) | Monoklonale antikoerper. | |
| FI863543A7 (fi) | Superoksididismutaasin ilmentäminen eukarioottisissa soluissa. | |
| FI880636A0 (fi) | Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter. | |
| ZA95968B (en) | Interferon alpha/beta binding protein its preparation and use | |
| ATE320266T1 (de) | Induktion von antigen-spezifischen t-zellen durch interferon | |
| DK643188D0 (da) | Ekspression af hiv-proteiner i e.coli og s.cerevisiae | |
| IT8420419V0 (it) | Struttura di testa, provvista di occhi mobili, applicabili su pupazzi in genere. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1100528 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |